11/18/2024
6:15 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/18/2024
5:46 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/14/2024
3:53 PM | Cellectar Biosciences (Subject)
Nantahala Capital Management, LLC (Filed by)
| Form SCHEDULE 13G/A | |
11/01/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/29/2024
4:03 PM | Cellectar Biosciences (Filer)
| Form 10-Q/A | |
10/29/2024
4:09 PM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/29/2024
3:56 PM | Cellectar Biosciences (Filer)
| Form 10-K/A | |
|
08/23/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2024
6:15 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
08/13/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/23/2024
11:15 PM | Cellectar Biosciences (Filer)
| Form EFFECT | |
07/23/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/22/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/11/2024
4:37 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
07/11/2024
4:15 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2024
3:46 PM | Cellectar Biosciences (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
05/16/2024
5:05 AM | Cellectar Biosciences (Filer)
| Form DEFR14A | |
05/14/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/14/2024
5:32 AM | Cellectar Biosciences (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2024
3:58 PM | Cellectar Biosciences (Filer)
| Form DEF 14A | |
04/26/2024
3:59 PM | Cellectar Biosciences (Filer)
| Form DEFA14A | |
04/25/2024
7:01 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
03/27/2024
5:45 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/27/2024
5:30 AM | Cellectar Biosciences (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2024
7:31 PM | Cellectar Biosciences (Subject)
Rosalind Advisors, Inc. (Filed by)
| Form SC 13G/A | |
02/14/2024
2:23 PM | Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G/A | |
02/07/2024
5:58 PM | Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024
5:03 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
01/31/2024
7:00 AM | ADAR1 Partners, LP (Filed by)
Cellectar Biosciences (Subject)
| Form SC 13G | |
01/09/2024
5:02 AM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
7:04 PM | CARUSO JAMES V (Reporting)
Cellectar Biosciences (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:04 PM | Cellectar Biosciences (Issuer)
Longcor Jarrod (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:05 PM | Cellectar Biosciences (Issuer)
Shustov Andrei (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:07 PM | Cellectar Biosciences (Issuer)
Kolean Chad J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
7:09 PM | Cellectar Biosciences (Issuer)
Lea Darrell Shane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/07/2023
4:15 PM | Cellectar Biosciences (Subject)
LYTTON LAURENCE W (Filed by)
| Form SC 13G | |
12/05/2023
5:01 AM | Cellectar Biosciences (Subject)
HIRSCHMAN ORIN (Filed by)
| Form SC 13G | |
11/29/2023
3:31 PM | Cellectar Biosciences (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
